Lotus Eye Hospital and Institute Limited

NSE:LOTUSEYE.NS

69.89 (INR) • At close November 5, 2024
Bedrijfsnaam Lotus Eye Hospital and Institute Limited
Symbool LOTUSEYE.NS
Munteenheid INR
Prijs 69.89
Beurswaarde 1,453,453,407
Dividendpercentage 0.83%
52-weken bereik 48.5 - 111
Industrie Medical Care Facilities
Sector Healthcare
CEO Dr. Kuttapalayam Songappan Ramalingam M.D.
Website https://www.lotuseye.org

An error occurred while fetching data.

Over Lotus Eye Hospital and Institute Limited

Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular

Vergelijkbare Aandelen

Aarey Drugs & Pharmaceuticals Limited logo

Aarey Drugs & Pharmaceuticals Limited

AAREYDRUGS.NS

62.78 INR

Vaishali Pharma Limited logo

Vaishali Pharma Limited

VAISHALI.NS

18.75 INR

Alpa Laboratories Limited logo

Alpa Laboratories Limited

ALPA.NS

111.64 INR

Bal Pharma Limited logo

Bal Pharma Limited

BALPHARMA.NS

123.23 INR

Mangalam Drugs & Organics Limited logo

Mangalam Drugs & Organics Limited

MANGALAM.NS

111.78 INR

SMS Lifesciences India Limited logo

SMS Lifesciences India Limited

SMSLIFE.NS

1,325 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)